First Patient in United Kingdom Treated With AcceleDent

HOUSTON, Oct. 29 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device for orthodontics, has just completed the sale of the product to several key opinion leaders in the United Kingdom. Doctors Gerry Bellman, Angelos Alvanos, and Asif Chatoo are in private practice in the London area while Dr. Lars Christensen is in private practice in Oxford.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients wear in the mouth for twenty minutes daily. It generates a light microvibration force which modulates the bone tissue remodeling process and accelerates orthodontic tooth movement. The device is hands-free and allows the user flexibility to carry out most routine tasks during the twenty-minute use session.

Dr. Bellman, an orthodontic specialist, is the first to treat a patient outside of the USA where the Company has been conducting human clinical trials. The patient is a 28-year old female initially being treated with a fixed orthodontic appliance, with a treatment plan to later include a clear aligner (Invisalign). The doctor and patient were very excited by how easy the AcceleDent System is to use and look forward to a significantly reduced treatment time. Dr. Bellman commented, "I was very excited to fit the first AcceleDent appliance to a patient in the UK. It was extremely easy to fit and my patient found it very simple to position in her mouth and use. I look forward to monitoring the accelerated movement of her teeth over the coming months."

Results from the initial clinical trial demonstrated an overall tooth movement rate of 2.1 mm per month, which is 30% to 50% faster than what is reported in the literature. This same study further demonstrated the safety of the AcceleDent System through a detailed measurement and statistical analysis of root resorption yielding mean values below 0.5 mm. It should be noted that 0.5 mm is well below the levels of 2 mm, or one-third of the root length, considered clinically significant by researchers.

OrthoAccel Technologies, an early-stage, private company, is presently controlling the availability of the AcceleDent System in the UK to a select group of orthodontic specialists. In this manner, the product presentation, doctor support materials, and Company logistical systems can be fine tuned before a broader UK market release planned for October 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is the developer of the AcceleDent System, a new device for enhancing orthodontic care. This device has been studied to verify that it safely reduces treatment duration for wearing braces by applying gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complimentary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be requested at info@orthoaccel.com

Contact: Michael K. Lowe, 281.798.5318